Down Syndrome – Page 2 – Waisman Center – UW–Madison

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer’s disease: a cross-sectional study

Cognitive and functional performance and plasma biomarkers of early Alzheimer’s disease in Down syndrome

Measurement of synaptic density in Down syndrome using PET imaging: a pilot study

Alzheimer’s polygenic risk scores are associated with cognitive phenotypes in Down syndrome

Transcriptional consequences of trisomy 21 on neural induction

Characterizing the emergence of amyloid and tau burden in Down syndrome

AT(N) biomarker profiles and Alzheimer’s disease symptomology in Down syndrome

Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts

Weight Loss and Alzheimer’s Disease in Down Syndrome

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome